Skip to main content
Fig. 2 | Journal of Orthopaedic Surgery and Research

Fig. 2

From: Neohesperidin promotes the osteogenic differentiation of bone mesenchymal stem cells by activating the Wnt/β-catenin signaling pathway

Fig. 2

A NEO dose-dependently increased the osteogenesis-related genes. a Relative expression of RUNX2 expression in control and NEO treatment groups. b Relative expression of BMP2 expression in control and NEO treatment groups. c Relative expression of osteocalcin expression in control and NEO treatment groups. d Relative expression of β-catenin expression in control and NEO treatment groups

Back to article page